NLRP3 and acute respiratory distress syndrome: Both METTL14 siRNA and MCC950 (NLRP3 inhibitor) administration decreased the lung wet/dry ratio in ALI mice, indicating an alleviation of pulmonary edema associated with ALI/ARDS.